Cannabidiol (CBD) and Δ(9)-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial

INTRODUCTION: Insomnia is a highly prevalent and costly condition that is associated with increased health risks and healthcare utilisation. Anecdotally, cannabis use is frequently reported by consumers to promote sleep. However, there is limited research on the effects of cannabis on sleep and dayt...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMJ Open
Prif Awduron: Suraev, Anastasia, Grunstein, Ronald R, Marshall, Nathaniel S, D'Rozario, Angela L, Gordon, Christopher J, Bartlett, Delwyn J, Wong, Keith, Yee, Brendon J, Vandrey, Ryan, Irwin, Chris, Arnold, Jonathon C, McGregor, Iain S, Hoyos, Camilla M
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2020
Pynciau:
Pharmacology and Therapeutics
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7239553/
https://ncbi.nlm.nih.gov/pubmed/32430450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-034421
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg